Imperial Innovations is striking it rich in the UK’s golden triangle having seen the value of its portfolio soar almost 40 per cent to £252 million in the year to July 31.
Business Weekly tells you where the hot money is placed on Cambridge cluster companies – and who has ventured it. If you’re an investor or potential collaborator you need to know how well a certain business is funded before you make your move.
Imperial Innovations in Cambridge last night pledged to maximise a £200 million war chest to fund new technology plays in addition to its own portfolio companies in the UK.
Anglia Capital, headed up by Struan McDougall, has expanded with a move to Norwich Research Park in a bid to exploit the region’s rapid growth sectors.
The University of Cambridge is raising a third enterprise fund this month having broken its early stage investment record for a second year running, approving nine seed fund investments for a total of £2.7 million – an increase on the £2.3m invested in 2012/13.
Companies in Cambridge are being urged to take a look at a bold new $200m third venture capital fund from DN Capital LLP – one of the UK’s leading venture and growth investors.
Cambridge ideas may have changed the world but all too often those innovations are sold by the founders before they realise their potential as multi-million pound companies.
Peter Cowley, a serial investor in the Cambridge technology heartland, was last night named Angel Investor of the Year at the UK Business Angels Association's Investment Awards.
Cambridge entrepreneur Peter Cowley is one of two additions to the investment committee of the Angel CoFund, a £100 million UK Government-backed fund for supporting and growing British SMEs.
Cambridge and London based investment group Imperial Innovations is planning to raise £150 million to underpin future investments in its UK science and technology stronghold.
Early stage life science and health technology companies plus university spin-outs in the Cambridge cluster have been alerted to a new $80 million fund – backed by Big Pharma player Eli Lilly – designed to take translational UK R & D from the lab to the marketplace.
A new test-bed fund to help companies trial innovation prototypes in live business environments has been launched in Peterborough – and companies from the Cambridge technology cluster and elsewhere in the UK can use the facility remotely.
Imperial Innovations, which has bolstered its portfolio since setting up in the Cambridge UK technology cluster, has ramped up revenues and profits in a transformational last six months – and it says it is sitting on more potential blockbusters.
Imperial Innovations, which is thriving from its base in the Cambridge UK technology cluster, is predicting great things from fast-growing investee company Circassia Pharmaceuticals, which is pioneering hay fever and cat allergy cures.
Cambridge UK technology investor, Amadeus Capital Partners, has cashed in on the sale of Italian business Octo Telematics for €405m to Renova Group.
Imperial Innovations has become one of the most active investors in the Cambridge UK technology cluster.
The Cambridge UK technology cluster is one of the key focal points of a new $100 million fund launched by KPMG.
- Successes in Cambridge highlight cluster’s ‘incredible’ tech scene
- Investment first launched in Cambridge
- Cable backs new initiative to fund small business
- Cambridge Angels find more cash for bug busters
- Evergreen angel spreads its wings
- Healthcare equipment still high on the list for VCs
- Cambridge alerted to €80 billion robotics research cash
- £4m TSB bait for Internet of Things
- New crowdfunding ‘bank’ hits the streets
- Hauser hails new £1m University fund
- Wellcome Trust revamps key research fund
- VCs face crisis of trust
- Angels close in on 11 new investments
- China overtakes UK for VC funding
- Norwich Research Park launches angel initiative
- New £40m solar VCT launched
Page 1 of 3